OrbiMed Investor
OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.
Invests into
Technology:
Cell_Therapies, Geroscience
Industry:
AI
Headquarters:
New York, New York, United States
Founded Date:
1989-01-01
Employees Number:
101-250
Funding Status:
undisclosed
Investor Type:
Private Equity Firm
Investment Stage:
Debt, Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity
Number Of Exits:
224
Acquisitions Number:
Made Acquisitions
Investors Number:
580
Estimated Revenue:
$1M to $10M
Register and Claim Ownership